latest blog entries
Loading...
Branding...
latest headlines for company on cafepharma
The Motley Fool
Sun, 06/16/13 - 11:33 am
TheStreet.com
Fri, 06/07/13 - 8:07 am
tags: ACH-3102, Achillion, Afrezza, Allovectin, ALN-TTR02, Alnylam, Amicus Therapeutics, Amigal, BIOD-123, Biodel, CCX140, ChemoCentryx, clinical trials, CNDO-201, Contrave, Coronado Biosciences, enobosarm, gevokizumab, GSK, GTx, Keryx, MannKind, Merrimack Pharmaceuticals, MM-398, Orexigen, Rockwell Medical, Soluble Ferric Pyrophosphate, sovaprevir, Takeda, Vical, Xoma, Zerenex
Motley Fool
Sun, 04/28/13 - 12:13 pm
tags: Achillion, Avanir, Gilead Sciences, GSK, Medivation, Pfizer, Theravance
Seeking Alpha
Tue, 04/16/13 - 11:55 am
tags: AbbVie, Achillion, Bristol-Myers Squibb, Gilead, Idenix, Merck, sofosbuvir
TheStreet.com
Tue, 04/02/13 - 10:58 am
tags: AbbVie, Achillion, Aegerion, Amarin, Arena Pharmaceuticals, AstraZeneca, Aveo Pharmaceutical, Biogen Idec, Bristol-Myers Squibb, Delcath, Dendreon, Depomed, Gilead, GSK, Merck, NewLink Genetics, Raptor Pharmaceuticals, Rigel, Sangamo BioSciences, Sucampo, Titan Pharmaceuticals, Valeant Pharmaceuticals, Vertex Pharmaceuticals, Vivus, Zogenix
Motley Fool
Wed, 02/27/13 - 12:24 pm
Motley Fool
Wed, 01/16/13 - 1:12 pm
TheStreet.com
Wed, 01/02/13 - 1:18 pm
Seeking Alpha
Wed, 01/02/13 - 12:47 pm
Motley Fool
Sun, 12/30/12 - 1:15 pm
tags: Abbott Laboratories, Achillion, Gilead Sciences, GSK, HCV, hepatitis C, Idenix, JNJ, Merck, Vertex Pharmaceuticals
Motley Fool
Fri, 12/28/12 - 12:36 pm
tags: Abbott Labs, Achillion, Bristol-Myers Squibb, Gilead, GSK, hepatitis C, Idenix, JNJ, Merck, Vertex Pharmaceuticals
Motley Fool
Sat, 12/08/12 - 12:17 pm
tags: ACH-1625, Achillion, Gilead Sciences, hepatitis C, Medivir, sofosbuvir, TMC435
Seeking Alpha
Fri, 11/30/12 - 1:10 pm
tags: Achillion, Gilead, hepatitis C, Idenix, Medivir, Merck, Vertex Pharmaceuticals
Motley Fool
Sat, 11/24/12 - 1:01 pm
Last 30 twitter posts
-
RT @cafepharma: Biotechs Lose Ground As Achillion Takes a Dive: The Motley Fool Sun, 06/16/13 - 11:33 am t.co/ss69joqpxw
-
Biotechs Lose Ground As Achillion Takes a Dive via Latest Headlines from Cafepharma - The Motley ... t.co/sfV3kLwx6q
-
Biotechs Lose Ground As Achillion Takes a Dive: The Motley Fool Sun, 06/16/13 - 11:33 am t.co/ss69joqpxw
-
Biotechs Lose Ground As Achillion Takes a Dive: Biotechs Lose Ground As... t.co/y06OLcDf4w
-
RT @Sachakin: D'après Adam Feuerstein, 6 #Biotechs pourraient se faire racheter dans les prochains mois: BioMarin, Onyx, Medivation, Achill…
-
Biotechs Lose Ground As Achillion Takes a Dive t.co/96g012R21M
-
D'après Adam Feuerstein, 6 #Biotechs pourraient se faire racheter dans les prochains mois: BioMarin, Onyx, Medivation, Achillion et Incyte..
-
Biotechs Lose Ground As Achillion Takes a Dive: Achillion makes up around 2% of the weight of the SPDR Biotech... t.co/fgGoJs0voW
-
Biotechs Lose Ground As Achillion Takes a Dive: Achillion makes up around 2% of the weight of the SPDR Biotech... t.co/UYKbhO3P21
-
#Fitness #WeightLoss Biotechs Lose Ground As Achillion Takes a Dive t.co/5CD4MkOvwl #TeamFollowBack
-
#Health #WeightLoss Biotechs Lose Ground As Achillion Takes a Dive t.co/7HYTKnkCeW #TeamFollowBack
-
Biotechs Lose Ground As Achillion Takes a Dive: t.co/taQZgSrbrx
-
t.co/whWclkmgss Headlines: Biotechs Lose Ground As Achillion Takes a Dive t.co/DO1vLIWoa1
-
Biotechs Lose Ground As Achillion Takes a Dive t.co/HEqY36iaZw
-
Biotechs Lose Ground As Achillion Takes a Dive t.co/TNbZL76I19 #biotech
-
Biotechs Lose Ground As Achillion Takes a Dive: Filed under: Investing Biotechnology'... t.co/1riqRhiGa2 t.co/dpqXQbq6Ds
-
Binnen 10 dagen: walsen door het paleis van Sissi #achillion #Corfu, zonnen op witte stranden & zwemmen in een turquoise zee #COUNTDOWN
-
$ACHN Large call spread in Achillion Pharma this afternoon doubles up a trade opened May 31 when shares were about 50c above today's...
-
Commit To Buy Achillion Pharmaceuticals At $5, Earn 20% t.co/r2BKbAEygW #biotech
-
Commit To Buy Achillion Pharmaceuticals At $5, Earn 20%: t.co/7OGfypLnXZ
-
Achillion to present at Wells Fargo 2013 Healthcare Conf on 6/18/13 @ 8:50am & 10:00 am Webcast here: t.co/oJ3YEQ5swu $ACHN #hcv
-
15037 р.! Греция, Калампаки, Achillion Palace Hotel Kalampaki 4* на 13.06.13 на 4 дней!
-
#daytrading Achillion to Present at the Wells Fargo 2013 Healthcare Conference: NEW HAVEN,... t.co/rmovDxFBBe #pennystocks #money
-
Achillion to Present at the Wells Fargo 2013 Healthcare Conference t.co/DmhI4CVz0N
-
Achillion to Present at the Wells Fargo 2013 Healthcare Conference t.co/bQFe50cujU #biotech
-
$ACHN Achillion to Present at the Wells Fargo 2013 Healthcare Conference.. t.co/JN0nQp0GMy
-
Insider Buying Achillion Pharmaceuticals, Inc. (ACHN) On The Verge Of FDA ... ...
-
Insider Buying Achillion Pharmaceuticals, Inc. (ACHN) On The Verge Of FDA News And Technical Breakout?: Inside... t.co/GOAvZkiPoJ
-
Sporades Islands flotilla 2013 / Checking out Achillion t.co/aIoq21JHQk
Latest Health Message Board Posts
... this month. Read more: http://www.businessweek.com/news/2012-08-28/achillion-takeover-looms-as-hepatitis-treatments-fail-real-m-and-a ---------------------------------------------------------------------------------------------------- Please use careful ...
Posted by:
Cheesegrater
at
2013-03-20 05:00:00
on
medhelp.org
... /ACHN_News_2012_8_7_General.pdf I found a poster on this trial that went out in for EASL in April 2012 http://www.achillion.com/PL/pdf/ACHN_ACH-1625_PH2_EASL12.pdf Some of the numbers in Segment 2, table 3 do not agree with the numbers mentioned ...
Posted by:
veteranB
at
2012-10-22 05:00:00
on
medhelp.org
... 2013, which means filing would be postponed until mid-2014. In addition to Gilead and BMS, Roche AG, Johnson & Johnson, Achillion Pharmaceuticals Inc., Abbott and Idenix Pharmaceuticals Inc. all have candidates they are developing for interferon-free HCV ...
Posted by:
veteranB
at
2012-10-20 05:00:00
on
medhelp.org
... of chronic hepatitis C (HCV). ACH-3102 is a pan-genotypic second-generation NS5A inhibitor against HCV that was discovered by Achillion and is currently being evaluated in a Phase 1 clinical trial. Fast Track designation was requested for ACH-3102 for its ...
Posted by:
rpooo
at
2012-10-06 05:00:00
on
medhelp.org
This was a brand new concept Vertex and Merck were coming out with .Because they have led the way with this class of drug,.it shouldn't take near as long for Tibotec(TMC435) and Achillion to get their same class drugs (protease) to market . JMO Will
Posted by:
Cheesegrater
at
2012-08-07 05:00:00
on
medhelp.org
Hhere is a list of Pharma stocks that are volatile as of this morning. Abbott,Achillion,Astra Zeneneca, Merck, Pharmasett,,Tibotec,Boehringer Ingelheim, BMS,Gilead,Anady"s,Pfizer,,Vertex.... All of the above currently are in the HCV future ...
Posted by:
orphanedhawk
at
2012-07-31 05:00:00
on
medhelp.org
... board for Genentech, Vertex, Merck, Gilead, BMS, Abbott, Phenomix, Tibotec, Pharmasset, Pfizer, Conatus, 3RT, Novartis, J&J, Achillion, and Regulus; and receiving grants or contracts from Genentech, Vertex, Gilead, BMS, Abbott, Quest, Conatus, Tibotec ...
Posted by:
rivll
at
2012-05-17 05:00:00
on
medhelp.org
... attracted others than the Big Three already mentioned. Companies testing therapies, either alone or together, include Achillion Pharmaceuticals Inc. (NASDAQ: ACHN), Idenix Pharmaceuticals Inc. (NASDAQ: IDIX), Merck (NYSE: MRK) and Vertex Pharmaceuticals ...
Posted by:
willbb
at
2012-01-07 06:00:00
on
medhelp.org
... attracted others than the Big Three already mentioned. Companies testing therapies, either alone or together, include Achillion Pharmaceuticals Inc. (NASDAQ: ACHN), Idenix Pharmaceuticals Inc. (NASDAQ: IDIX), Merck (NYSE: MRK) and Vertex Pharmaceuticals ...
Posted by:
willbb
at
2011-10-10 05:00:00
on
medhelp.org
... an interesting article in Seeking Alpha. It seems somebody thinks the new HCV drugs will be effective against HIV. http://seekingalpha.com/article/1272281-achillion-a-tiny-biopharmaceutical-stock-with-tremendous-potential?source=yahoo comments? Cheese
Posted by:
mikesimon
at
2010-11-10 06:00:00
on
medhelp.org